Senti Bio Joins Webull Corporate Connect Service Platform
Company advancing off-the-shelf CAR-NK cell therapy programs for oncology indications with lead candidate, SENTI-202, in clinical development for ...
The Business & Financial Times on MSN9h
Stem cell therapy best bet at reducing rising NCD burden – expert
By Ebenezer Chike Adjei NJOKU Dr. Davies Kofie Adedze, a leading advocate for regenerative medicine, has stated that stem cell therapy could significantly reduce the country’s burden of ...